Patient roadmap and economic burden of chronic tick-borne illness and post-treatment Lyme disease syndrome in Ireland, and public health issues arising

Lyme borreliosis (LB), commonly referred to as Lyme disease (LD), is a prominent global health issue, exhibiting a seroprevalence rate of 14.5%. Heightened incidence levels of LD have been recorded in parts of Europe, Poland, Eastern Europe, and the Baltic States. The research aimed to inform the co...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Gordana Avramovic, Leona Gilbert, Sławomir Kujawski, Sigrid Blehle, Pascal Jollivet-Courtois, Paweł Zalewski, Nabin Adhikari, Kunal Garg, John Shearer Lambert
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2026-06-01
Sarja:	Frontiers in Public Health
Aiheet:	chronic Lyme disease cost Lyme patient roadmap post-treatment Lyme disease syndrome tick-borne infections
Linkit:	https://www.frontiersin.org/articles/10.3389/fpubh.2026.1667043/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!